Revenue breakdown by Products & Services
Revenue breakdown by Geography

Pfizer's Revenue by Region

In fiscal year 2025, Pfizer's revenue by geographical region are as follows:

  • Developed Rest Of World: $16.19 B
  • Emerging Markets: $9.31 B
  • UNITED STATES: $37.08 B

Learn more about Pfizer’s Revenue by Products

Check out competitors to Pfizer in a side-by-side comparison.

Explore additional financial metrics for Pfizer.

Continue reading...

The above chart shows Pfizer's revenue percentage share by geographical region.

In fiscal year 2023, Pfizer's revenue by region is as follows:

  • Developed Europe generated $11.65 B in revenue, representing 19.92% of its total revenue.
  • Developed Rest Of World generated $7.76 B in revenue, representing 13.27% of its total revenue.
  • Emerging Markets generated $12.00 B in revenue, representing 20.51% of its total revenue.
  • UNITED STATES generated $27.09 B in revenue, representing 46.31% of its total revenue.

The biggest region for Pfizer is the UNITED STATES, which represents 46.31% of its total revenue.
The smallest region for Pfizer is the Developed Rest Of World, which represents 13.27% of its total revenue.

The above chart shows Pfizer's revenue percentage share by geographical region.

In fiscal year 2024, Pfizer's revenue by region is as follows:

  • Developed Rest Of World generated $16.06 B in revenue, representing 25.24% of its total revenue.
  • Emerging Markets generated $8.88 B in revenue, representing 13.95% of its total revenue.
  • UNITED STATES generated $38.69 B in revenue, representing 60.81% of its total revenue.

The biggest region for Pfizer is the UNITED STATES, which represents 60.81% of its total revenue.
The smallest region for Pfizer is the Emerging Markets, which represents 13.95% of its total revenue.

The above chart shows Pfizer's revenue percentage share by geographical region.

In fiscal year 2025, Pfizer's revenue by region is as follows:

  • Developed Rest Of World generated $16.19 B in revenue, representing 25.87% of its total revenue.
  • Emerging Markets generated $9.31 B in revenue, representing 14.88% of its total revenue.
  • UNITED STATES generated $37.08 B in revenue, representing 59.25% of its total revenue.

The biggest region for Pfizer is the UNITED STATES, which represents 59.25% of its total revenue.
The smallest region for Pfizer is the Emerging Markets, which represents 14.88% of its total revenue.
Continue reading...

Summary Table

Geography (Percent Share) 2023 2024 2025
Developed Europe 19.92% 0% 0%
Developed Rest Of World 13.27% 25.24% 25.87%
Emerging Markets 20.51% 13.95% 14.88%
UNITED STATES 46.31% 60.81% 59.25%
Total Revenue 100% 100% 100%

The above chart shows the revenue trend of different segments of Pfizer.

In fiscal year 2025, the UNITED STATES generated the most revenue ($37.08 B), and the Emerging Markets generated the least revenue ($9.31 B).

The above chart shows growth drivers and a year-over-year comparison of different segments' revenue.

  • Developed Rest Of World revenue increased 0.82% ($131.00 M) from $16.06 B (in 2024) to $16.19 B (in 2025).
  • Emerging Markets revenue increased 4.89% ($434.00 M) from $8.88 B (in 2024) to $9.31 B (in 2025).
  • UNITED STATES revenue decreased -4.17% ($1.61 B) from $38.69 B (in 2024) to $37.08 B (in 2025).
  • Continue reading...

    Summary Table

    Region 2023 2024 2025
    Developed Europe $11.65 B - - - - -
    Developed Rest Of World $7.76 B - $16.06 B
    106.89%
    $16.19 B
    0.82%
    Emerging Markets $12.00 B - $8.88 B
    25.98%
    $9.31 B
    4.89%
    UNITED STATES $27.09 B - $38.69 B
    42.83%
    $37.08 B
    4.17%
    Total Revenue $58.50 B - $63.63 B
    8.77%
    $62.58 B
    1.65%